Jacques R. Seguin
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Jacques Seguin is the Chairman Of The Board at Emanate Biomedical. He Attended Paris-Sud University (Paris XI) during 1975-1985.
Investor Profile
Jacques R. Seguin has made 3 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Seed (33%)
- Pre Seed (33%)
- Series Unknown (33%)
Country Focus
- Israel (67%)
- Switzerland (33%)
Industry Focus
- Medical
- Medical Device
- Biotechnology
- Health Diagnostics
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
